Home > Compound List > Product Information
Bortezomib-D8 (Major)_Molecular_structure_CAS_)
Click picture or here to close

Bortezomib-D8 (Major)

Catalog No. B675702 Name Toronto Research Chemicals
CAS Number Website http://www.trc-canada.com
M. F. C19H25BN4O4 Telephone +1 (416) 665-9696
M. W. 384.2372 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage Hygroscopic, -20°C Freezer, Under Inert Atmosphere Chembase ID: 162700

SYNONYMS

IUPAC name
[(1R)-3-methyl-1-[(2R)-3-(2H5)phenyl-2-(pyrazin-2-ylformamido)(2H3)propanamido]butyl]boronic acid
IUPAC Traditional name
(1R)-3-methyl-1-[(2R)-3-(2H5)phenyl-2-(pyrazin-2-ylformamido)(2H3)propanamido]butylboronic acid
Synonyms
Velcade-D8, [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic Acid-D8

DATABASE IDS

PROPERTIES

Certificate of Analysis Download
Apperance Off-White Solid
Melting Point 115-117°C
Solubility Chloroform
Solubility DMSO
Solubility Ethanol
Solubility Methanol
MSDS Link Download
Storage Condition Hygroscopic, -20°C Freezer, Under Inert Atmosphere

DETAILS

Description (English)
Labelled Bortezomib, whcih the first proteasome inhibitor to be approved b the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryo

REFERENCES

  • Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005)